Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu.

Citations & References

  • Authors: Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H,
  • Journal: Clin Cancer Res (2007) 13:2936-2945
  • Product Usage: Labeling of herceptin for in vivo imaging of HER2/neu metastatic lesions
  • ID: PN66739
Catalog #s
D2184
F143
F1906
F1907
O6147
R6107
1a55850e4e1c7d984966c6f61762ecfb_Citations

Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared Imaging.

Citations & References

  • Authors: Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, Gandjbakhche A, Capala J,
  • Journal: Clin Cancer Res (2008) 14:3840-3849
  • Product Usage: Labeling of HER2-specific Affibody molecules via carboxy-terminal cysteine (Alexa Fluor 488, 680, 750 maleimides). (2) Trastuzumab (Herceptin) labeled using SAIVI Rapid Antibody Labeling Kits.
  • ID: PN66786
Catalog #s
A10254
A20344
A30459
S30045
S30046
ea6fda75801fc0f23ad25ab251ff5891_Citations

In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies.

Citations & References

  • Authors: Ogawa M, Regino CA, Choyke PL, Kobayashi H,
  • Journal: Mol Cancer Ther (2009) 8:232-239
  • Product Usage: Multiple labeling of humanized anti-HER2 monoclonal antibody (trastuzumab, Herceptin) to generate an optical probe with near-infrared fluorescence response to receptor-mediated internalization in tumors.
  • ID: PN67150
Catalog #s
A20008
A20108
421f51ad0b692460d1055a774c1b4e82_Citations